Skip to content
Home/Companies/Biotech/Horizon Discovery

Horizon Discovery

Biotech·UK·Exited 2017·Held 4yr
Entry
2013
Hold
4yr
Exit
2017

Who owns Horizon Discovery?

Horizon Discovery was owned by Parkwalk Advisors through Parkwalk Opportunities EIS Fund (2009 vintage) from 2013 to 2017, exited via Secondary.

Hand-verified · updated 2026-06-11

Parkwalk Advisors
Investor
Parkwalk Advisors
Parkwalk Opportunities EIS Fund · 2009 · VC

Key facts

HQUK
SectorBiotech
StatusAcquired
Exit Type
Secondary
Buyer
–
MOIC
–
Exit Year
2017

More from Parkwalk Opportunities EIS Fund

Other portfolio companies in the same fund.

1715 Labs
Exited 2023
AI/MLUK
ACAL Energy
Exited 2017
EnergyUK
Aqdot
Aqdot
Active
Deep TechUK
Arkivum
Arkivum
Active
SoftwareUK
Arvia
Arvia
Active
ClimateTechUK
Cytotrait
Active
BiotechUK· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Horizon Discovery

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Horizon Discovery?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Horizon Discovery.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue